Joseph P. Hagan, CEO: Regulus Therapeutics RGLS Buy · Filed 25/01/31

Trade details

Type: Insider buy
Amount: $54,500
Shares · price: 50,000 sh · $1.09 a share
Held after: 260,808 sh
Stock: Regulus Therapeutics RGLS
Person: Joseph P. HaganCEO
Trade date: 25/01/30
Filed: 25/01/31
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +23.7%

Regulus Therapeutics trades, last 26 weeks

What else happened in Regulus Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/31~25/03/01

Joseph P. Hagan's recent trades

Joseph P. HaganCEO
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$145.3K
115,290 sh
$145.3K
Filed 25/01/15
Traded 25/01/13
Joseph P. HaganCEO
Sell10b5-1 planRegulus Therapeutics
Sell10b5-1 plan
Regulus Therapeutics
RGLS
$14.8K
11,764 sh
$14.8K
Filed 25/01/15
Traded 25/01/14
Joseph P. HaganCEO
SellRegulus Therapeutics
Sell
Regulus Therapeutics
RGLS
$17.4K
14,580 sh
$17.4K
Filed 24/01/18
Traded 24/01/18
Joseph P. HaganDirector
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$2,878
272 sh
$2,878
Filed 23/05/23
Traded 23/05/19